Amneal Pharmaceuticals Affirms FY2026 Adj EPS Guidance of $0.95-$1.05 vs $1.00 Est; Affirms FY2026 Sales Guidance of $3.050B-$3.150B vs $3.100B Est

Benzinga Newsdesk www.benzinga.com Neutral 58.3%